Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 368

Results For "Global"

4822 News Found

Lupin Diagnostics launches its first regional reference lab in Patna
Clinical Trials | June 16, 2022

Lupin Diagnostics launches its first regional reference lab in Patna

Expanding diagnostics footprint in East India


Glenmark becomes the first company to launch Indacaterol + Mometasone FDC for asthma in India
News | June 16, 2022

Glenmark becomes the first company to launch Indacaterol + Mometasone FDC for asthma in India

Glenmark is the first company in India to market the innovative FDC of Indacaterol


Stelis Biopharma's two biologics manufacturing facilities receive EU cGMP accreditation
Drug Approval | June 16, 2022

Stelis Biopharma's two biologics manufacturing facilities receive EU cGMP accreditation

Stelis's small-scale cGMP manufacturing facility is designed to support smallscale commercial and cGMP clinical trial material generation


LG Chem’s new drug for obesity receives additional orphan drug designation by US FDA
News | June 16, 2022

LG Chem’s new drug for obesity receives additional orphan drug designation by US FDA

With this designation, LG Chem will receive benefits such as exclusive sales rights in the US market for seven years, subsidies and tax cuts for clinical testing costs in the US, and preliminary consulting support related to development


80% of hypertensive women found to be obese: Study
Healthcare | June 16, 2022

80% of hypertensive women found to be obese: Study

48% of people are either hypertensive or at risk of becoming hypertensive & 30% of people have a high Waist Hip Ratio (WHR) – an early indication of the onset of CVDs


QIAGEN selects TCS for cloud transformation strategy
Digitisation | June 16, 2022

QIAGEN selects TCS for cloud transformation strategy

QIAGEN has started its cloud transformation journey with the firm belief that cloud computing can be a key enabler of future business growth


ADC Therapeutics appoints David Gilman as Chief Business & Strategy Officer
People | June 15, 2022

ADC Therapeutics appoints David Gilman as Chief Business & Strategy Officer

Gilman will be responsible for all business development and portfolio strategy efforts globally.


Etihad Cargo signs MOU for sustainable pharmaceutical transportation solutions
Supply Chain | June 15, 2022

Etihad Cargo signs MOU for sustainable pharmaceutical transportation solutions

Becomes the first airline globally to develop and launch sustainable, temperature-controlled containers for the transportation of pharmaceuticals


CCI approves sale of biosimilars portfolio of Viatris to Biocon Biologics
News | June 15, 2022

CCI approves sale of biosimilars portfolio of Viatris to Biocon Biologics

The proposed transaction involves the sale of the global biosimilars portfolio of Viatris to Biocon Biologics


Cipla and DNDi launch child-friendly 4-in-1 antiretroviral treatment for HIV in South Africa
Public Health | June 15, 2022

Cipla and DNDi launch child-friendly 4-in-1 antiretroviral treatment for HIV in South Africa

This new formulation represents a significant improvement over protease inhibitor-containing paediatric ARV formulations that have been used in South Africa for decades.